We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -1.61% | 3.05 | 3.00 | 3.10 | 3.15 | 3.05 | 3.10 | 1,785,708 | 13:41:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.16 | 2.75M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/9/2023 11:55 | Jasonpugh is a compulsive liar, best not engage with it! | pinkpudycat | |
13/9/2023 04:46 | @JasonPugh Because you post utter nonsense to try and sucker others into buying at this high share price before the placing lands IF they secure support. Confirm how much THX have raised and point to me their press release of same or even ANY confirmation anywhere of a placing??? You wont be able to because its utter BS. There will be NO RNS tomorrow of same and further, THX do not need to raise cash for this as they have the IP anyway. My view stands that VAL ideally need to raise £2.4m before the end of this year for a 12 mth cash runway. IF it gets supported my view is £1m at 3.0p and £2m at 1.5p IF investors will support for a working capital raise. Meanwhile; you will get an RNS on the lab launch shortly and i suspect you will get some lab contract wins, the company will need to make some noise pre placing. But it would need a heck of a lot of lab wins to cover its base costs. The Break Even point is about £2.3m that's a lot of lab business. Based on CENKOS calculation, with lab work being so labour intensive, 1X Scientist at full capacity can add £175k revenue and £25k bottom line. They have 3. So staff numbers in labs will need to materially increase as more client business won, hence payroll going even higher but as i say they need a heck of a lot of wins. Its now simply a question of IF VAL can secure placing support or not, that is the burning question here. You ramping about THX getting cash to VAL after 2 years will make no difference but it could encourage a few traders i guess. Some nutcase brought 200,000 today at 6.3p, must be an existing holder down averaging or someone speculating on a small bounce for profit so they are out there but anyone researched is not going to fall for your ramping nonsense. | porky9 | |
13/9/2023 00:17 | Again porky you achieved c- read my post again. Theormrx are ABOUT TO RELEASE…EXPECT They have substantially more clients than valirx. An rns tomorrow or next week is inevitable on theormrx being successful. @Porky. You really attack good news Why regarding valirx? | jasonpugh | |
12/9/2023 16:42 | In that case @JasonPugh we can look forward to an RNS at open tomorrow from VAL confirming that THX has completed funding and is expected to complete on 201 shortly. VAL are hardly going to sit on news of that nature. Frankly, i think you are full of sh@t and you are trying a mini pump, in order to try and sucker a few in before you offload the few shares you have prior to their discounted placing due shortly IF they can secure support. | porky9 | |
12/9/2023 14:17 | If that was the case then the price would have a 0 at the end! | wulber | |
12/9/2023 13:09 | Im happy but sad. Im happy that myself and my fiancée have nearly half mill shares.. Im sad because all other assets locked up in other private equity so cannot buy more as have received news that theormrx are about to release news to the effect that their funding round has been successful not only for 201 but also for “Rowe Price Associates, primecap management company, Fidelity Management & research co…” Amongst others. A substantial amount raised. DYOR 👌 Absolutely no placing required | jasonpugh | |
12/9/2023 11:17 | Nothing but selling here at the moment - will it break 6p? | wulber | |
08/9/2023 13:24 | Read the guardian newspaper from 20 hrs ago. Quote “uk researchers were among the greatest beneficiaries of previous horizon programmes and the country sometimes landed more awards than germany, at the forefront of European science..” does this sound good or bad porky? DYOR 👌 . | jasonpugh | |
08/9/2023 12:45 | Porky. Due to the tremendous news from horizon i have reconsidered my position. This is based on the potential to get grants. Show me on quote from any of the media to substantiate your comment regarding grants. Lol. Quote your sources. Harvard style please. | jasonpugh | |
08/9/2023 12:16 | well the two full time rampers on the PYC board will keep posting anything including that the VAL THX deal will be worth millions to PYC - when in reality IF a miracle came and the £1.3m paid to VAL (which wont happen anyway) they would see just 6% ie £78k. Frankly, its worth the square route of FA As for excitement over grants, give me strength, you don't value a business on if it can get a free grant or not. I dread to think how many applications across the entire EU continent will be applying especially as we are in a major biotech funding drought. As for genius at getting grants, yes, they are also veterans at raising placing cash. I take it your recent ramping is down to the fact that you have taken a punt on a few shares???? lets hope the lab opening news and a couple of non specified value lab wins helps lift the share price for you to get out at profit before the 2p placing lands in the next few weeks - clock ticking | porky9 | |
08/9/2023 10:18 | Do some fundamental analysis on this horizon. Then read the Financial times. Bbc. Sky mews and Gov.uk. Its immense news. Mark eccleston whos on the Valirx scientific board is a genius at getting grants. This synergy with lab contracts has changed my view considerably on the probability of a placing. Even the investors in physiomics feel that success for valirx will trickle into physiomics. This is massive news. Imho. 👌 | jasonpugh | |
08/9/2023 10:10 | Look @JasonPugh I’m not sure what I make of a CEO posting a tweet saying “fantastic News” and then later saying she was referring to Horizon but her marketing team forgot to add the Horizon link Each to their own but come on, yes a Europeans grant fund opening is positive for the sector, not specifically that VAL would get anything this year. Meanwhile the die hards interpret that sort of tweet as meaning some fantastic news on 201 could land when it’s clearly not the case | porky9 | |
08/9/2023 09:52 | Siliconmark. I respect your comments (sledgehammer) but with the horizon news yesterday this has completely put to bed a placing in my view. Kindest regards Jason | jasonpugh | |
08/9/2023 09:43 | Jason, 2 weeks ago you said: “Conclusion. Placing required in or around January 2024. Expect 3p ish.” Porky, I don’t agree with everything you post but “JasonPugh - sometimes you post like a real tool” sums it up. | siliconmark | |
08/9/2023 09:01 | Valirx twitter just posted 5 mins ago just how this is good news. Forget placing at these ridiculous prices. Lab revenue coming in. Lab presentation. Oh and if as suzy claims 201 successful with Theoremrx this year then boom 💥 👌 | jasonpugh | |
08/9/2023 08:44 | With the horizon news yesterday can confirm that mark eccleston (on the scientific advisory board for valirx) will be applying for grants for valirx (wouldn’t tell me how much but he said this was really good news for bio) In my view with this and lab revenue the chances of a placing have diminished considerably. 👌 DYOR | jasonpugh | |
07/9/2023 08:09 | Uk to rejoin eu horizon research programme Financial time’s article this morning. It appears funds can be applied for from today from biotech companies for research. 💡 On GOV.uk latest UK joins horizon Europe under a new bespoke deal. para 2. “From today (Thursday 7th September) uk researchers can apply for grants …” DYOR | jasonpugh | |
06/9/2023 14:55 | @teamhanz69 LMOL - we will see, once the boiler room leave it will be back in the 1.4p - 1.8p range, come end of the financial year the new CEO will want to place and award himself options at the placing level suspect 1p again, As a business the new appointment is great and business recovering but they need 600k of revenue assuming costs similar and recent award was 125k the other one unstated. So YES moving in right direction but will need that bit more cash. Next placing is the one possibly to back for sure if it demonstrates clear route to profitability. Good luck | porky9 | |
06/9/2023 14:38 | @teaniraqihanz. Im still in it you thirdwit | jasonpugh | |
06/9/2023 13:49 | Wrong again Porky. You were saying about PYC? Jason Pugh, good to see you get busted under a false name on the telegram group and swiftly booted out. That did make me laugh. | teamhanz69 | |
01/9/2023 15:10 | @jasonpugh Its the greed that kills you Nobody ever made a loss taking a profit P&D cycle over at PYC closing shortly. The AIM market is becoming more and more like a casino by the day. If anyone actually did any research into PYC they would quickly see they need about £600k of new invoiced revenue to break even before another capital raise. A win of £125k helps and a good start but nowhere near enough. Not enough to justify a doubling of its market value in two days. Still the 1p placers wont be complaining that's for sure, nice work if you can get it, timing is everything. Well done on your 47% nice work | porky9 | |
01/9/2023 11:44 | Board in a closed period. Incoming news 👂 | jasonpugh | |
01/9/2023 11:41 | Some wonderfully high quality chat on here. Anyone who wants more, arguably better discussion, follow this link to a Val TG group: Appreciate it if Pugh and Porky wouldn't bother. | sidalmighty |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions